February 29, 2024
Snapshot Top 10: Dow Jones U.S. Pharmaceuticals Index



The Top 10 performing stocks in the Dow Jones U.S. Pharmaceuticals Index are shown for seven different investment strategies. Whether you are looking for value, growth or dividend stocks, or you want stocks that rank well overall, you can see the top 10 stock picks, together with how they rank on a scale of 1 to 100 from the perspective of different investment strategies. We have also added our newest Sentiment and 360° View ranks, which encapsulate the market voices of analysts and professional investors into a simple ranking for easily evaluating stocks. As an objective research provider, Obermatt has been refining its stock analysis algorithms for more than 10 years (no AI used here!)

Select any stock for the detailed analysis of that stock's performance across the different investment analyses. Please note that the Top 10 stocks focus only on Large to XX-Large companies.


What the six ranks mean

For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. The higher the rank, the better the stock performs than its peers. And, we do this for six investment strategies:

Value - shows how good of a value the stock is. Green is "inexpensive"; red is "expensive".

Growth - shows a company's growth potential. Green is "high growth" expected; red is "tough times ahead".

Safety - relates to the amount of debt a company has. Green is low debt level; red is high debt level.

Combined Financial - this isn't an average of the first three ranks but rather a consolidated view across several financial indicators. Green = good; red = tread carefully.

(NEW) Sentiment - quantifies professional analyst ratings and holdings as well as market pulse. Green = positive sentiment; red = skepticism (Only available to Premium Subscribers).

(NEW) 360° View - the ultimate rating with all financial and non-financial indicators.

Special Analysis: TOP 10 Dividend Investment Strategy

Many people ask for tips about dividend stocks. These are the Top 10 dividend stocks in the Dow Jones U.S. Pharmaceuticals Index as of February 29, 2024.

TOP 10 Dividend Investment Strategy Value Strategy DIVIDEND Value Strategy VALUE Combined Strategy COMBINED 360° Strategy 360° VIEW
1. Pfizer (XXL, US)  Pharmaceuticals
1. Pfizer (XXL, US)   Pharmaceuticals 100 92 76 71
2. Bristol-Myers Squibb (XXL, US)  Pharmaceuticals
2. Bristol-Myers Squibb (XXL, US)   Pharmaceuticals 98 94 33 16
3. Phibro Animal (L, US)  Pharmaceuticals
3. Phibro Animal (L, US)   Pharmaceuticals 98 100 94 70
4. Johnson & Johnson (XXL, US)  Pharmaceuticals
4. Johnson & Johnson (XXL, US)   Pharmaceuticals 96 63 60 27
5. Merck & Co. (XXL, US)  Pharmaceuticals
5. Merck & Co. (XXL, US)   Pharmaceuticals 87 52 36 76
6. Eli Lilly (XXL, US)  Pharmaceuticals
6. Eli Lilly (XXL, US)   Pharmaceuticals 85 19 51 64
7. Zoetis (XL, US)  Pharmaceuticals
7. Zoetis (XL, US)   Pharmaceuticals 84 17 37 67

☀ This company has a special achievement which is documented on its stock research page.

February 29, 2024. Top 10s are published weekly following the . ( or for more stocks)


D.J. US Pharmaceutical Top 10: Obermatt 360° Investment Strategy

TOP 10 Obermatt 360° Investment Strategy 360° Strategy 360° VIEW Value Strategy VALUE Combined Strategy COMBINED Sentiment Strategy SENTIMENT
1. Pacira BioSciences (M, US)   Pharmaceuticals
1. Pacira BioSciences (M, US)   Pharmaceuticals 100 67 98 70
2. Amphastar (M, US)   Pharmaceuticals
2. Amphastar (M, US)   Pharmaceuticals 92 12 78 81
3. Prestige (L, US)   Pharmaceuticals
3. Prestige (L, US)   Pharmaceuticals 91 42 54 100
4. Heska (S, US)   Health Care Equipment
4. Heska (S, US)   Health Care Equipment 88 40 55 46
5. Merck & Co. (XXL, US)   Pharmaceuticals
5. Merck & Co. (XXL, US)   Pharmaceuticals 76 52 36 94
6. Pfizer (XXL, US)   Pharmaceuticals
6. Pfizer (XXL, US)   Pharmaceuticals 71 92 76 49
7. Phibro Animal (L, US)   Pharmaceuticals
7. Phibro Animal (L, US)   Pharmaceuticals 70 100 94 10
8. Zoetis (XL, US)   Pharmaceuticals
8. Zoetis (XL, US)   Pharmaceuticals 67 17 37 81
9. Eli Lilly (XXL, US)   Pharmaceuticals
9. Eli Lilly (XXL, US)   Pharmaceuticals 64 19 51 94
10. Nektar (S, US)   Pharmaceuticals
10. Nektar (S, US)   Pharmaceuticals 52 70 91 4

February 29, 2024. Top 10s are published weekly following the . ( or for more stocks)


D.J. US Pharmaceutical Top 10: Sentiment Investment Strategy

TOP 10 Sentiment Investment Strategy Sentiment Strategy SENTIMENT Value Strategy VALUE Combined Strategy COMBINED 360° Strategy 360° VIEW
1. Prestige (L, US)   Pharmaceuticals
1. Prestige (L, US)   Pharmaceuticals 100 42 54 91
2. Merck & Co. (XXL, US)   Pharmaceuticals
2. Merck & Co. (XXL, US)   Pharmaceuticals 94 52 36 76
3. Eli Lilly (XXL, US)   Pharmaceuticals
3. Eli Lilly (XXL, US)   Pharmaceuticals 94 19 51 64
4. Amphastar (M, US)   Pharmaceuticals
4. Amphastar (M, US)   Pharmaceuticals 81 12 78 92
5. Zoetis (XL, US)   Pharmaceuticals
5. Zoetis (XL, US)   Pharmaceuticals 81 17 37 67
6. Pacira BioSciences (M, US)   Pharmaceuticals
6. Pacira BioSciences (M, US)   Pharmaceuticals 70 67 98 100
7. Johnson & Johnson (XXL, US)   Pharmaceuticals
7. Johnson & Johnson (XXL, US)   Pharmaceuticals 49 63 60 27
8. Pfizer (XXL, US)   Pharmaceuticals
8. Pfizer (XXL, US)   Pharmaceuticals 49 92 76 71
9. Heska (S, US)   Health Care Equipment
9. Heska (S, US)   Health Care Equipment 46 40 55 88

February 29, 2024. Top 10s are published weekly following the . ( or for more stocks)


D.J. US Pharmaceutical Top 10: Value Investment Strategy

TOP 10 Value Investment Strategy Value Strategy VALUE Growth Strategy GROWTH Combined Strategy COMBINED 360° Strategy 360° VIEW
1. Phibro Animal (L, US)   Pharmaceuticals
1. Phibro Animal (L, US)   Pharmaceuticals 100 15 94 70
2. Assertio Therapeutics (S, US)   Pharmaceuticals
2. Assertio Therapeutics (S, US)   Pharmaceuticals 98 1 89 48
3. Bristol-Myers Squibb (XXL, US)   Pharmaceuticals
3. Bristol-Myers Squibb (XXL, US)   Pharmaceuticals 94 3 33 16
4. Pfizer (XXL, US)   Pharmaceuticals
4. Pfizer (XXL, US)   Pharmaceuticals 92 39 76 71
5. Nektar (S, US)   Pharmaceuticals
5. Nektar (S, US)   Pharmaceuticals 70 37 91 52
6. Pacira BioSciences (M, US)   Pharmaceuticals
6. Pacira BioSciences (M, US)   Pharmaceuticals 67 71 98 100
7. Johnson & Johnson (XXL, US)   Pharmaceuticals
7. Johnson & Johnson (XXL, US)   Pharmaceuticals 63 21 60 27
8. Merck & Co. (XXL, US)   Pharmaceuticals
8. Merck & Co. (XXL, US)   Pharmaceuticals 52 85 36 76
9. Prestige (L, US)   Pharmaceuticals
9. Prestige (L, US)   Pharmaceuticals 42 67 54 91
10. Heska (S, US)   Health Care Equipment
10. Heska (S, US)   Health Care Equipment 40 54 55 88

February 29, 2024. Top 10s are published weekly following the . ( or for more stocks)


D.J. US Pharmaceutical Top 10: Growth Investment Strategy

TOP 10 Growth Investment Strategy Growth Strategy GROWTH Value Strategy VALUE Combined Strategy COMBINED 360° Strategy 360° VIEW
1. Eli Lilly (XXL, US)   Pharmaceuticals
1. Eli Lilly (XXL, US)   Pharmaceuticals 97 19 51 64
2. Amphastar (M, US)   Pharmaceuticals
2. Amphastar (M, US)   Pharmaceuticals 93 12 78 92
3. Merck & Co. (XXL, US)   Pharmaceuticals
3. Merck & Co. (XXL, US)   Pharmaceuticals 85 52 36 76
4. Zoetis (XL, US)   Pharmaceuticals
4. Zoetis (XL, US)   Pharmaceuticals 71 17 37 67
5. Pacira BioSciences (M, US)   Pharmaceuticals
5. Pacira BioSciences (M, US)   Pharmaceuticals 71 67 98 100
6. Prestige (L, US)   Pharmaceuticals
6. Prestige (L, US)   Pharmaceuticals 67 42 54 91
7. Heska (S, US)   Health Care Equipment
7. Heska (S, US)   Health Care Equipment 54 40 55 88
8. Supernus Pharma (M, US)   Pharmaceuticals
8. Supernus Pharma (M, US)   Pharmaceuticals 43 26 54 19
9. Catalent (XL, US)   Pharmaceuticals
9. Catalent (XL, US)   Pharmaceuticals 43 17 7 1
10. Pfizer (XXL, US)   Pharmaceuticals
10. Pfizer (XXL, US)   Pharmaceuticals 39 92 76 71

February 29, 2024. Top 10s are published weekly following the . ( or for more stocks)


D.J. US Pharmaceutical Top 10: Safety Investment Strategy

TOP 10 Safety Investment Strategy Safety Strategy SAFETY Value Strategy VALUE Combined Strategy COMBINED 360° Strategy 360° VIEW
1. Assertio Therapeutics (S, US)  Pharmaceuticals
1. Assertio Therapeutics (S, US)   Pharmaceuticals 100 98 89 48
2. Nektar (S, US)  Pharmaceuticals
2. Nektar (S, US)   Pharmaceuticals 98 70 91 52
3. Phibro Animal (L, US)  Pharmaceuticals
3. Phibro Animal (L, US)   Pharmaceuticals 92 100 94 70
4. Pfizer (XXL, US)  Pharmaceuticals
4. Pfizer (XXL, US)   Pharmaceuticals 91 92 76 71
5. Amphastar (M, US)  Pharmaceuticals
5. Amphastar (M, US)   Pharmaceuticals 87 12 78 92
6. Supernus Pharma (M, US)  Pharmaceuticals
6. Supernus Pharma (M, US)   Pharmaceuticals 82 26 54 19
7. Heska (S, US)  Health Care Equipment
7. Heska (S, US)   Health Care Equipment 78 40 55 88
8. Johnson & Johnson (XXL, US)  Pharmaceuticals
8. Johnson & Johnson (XXL, US)   Pharmaceuticals 73 63 60 27
9. Pacira BioSciences (M, US)  Pharmaceuticals
9. Pacira BioSciences (M, US)   Pharmaceuticals 73 67 98 100
10. Prestige (L, US)  Pharmaceuticals
10. Prestige (L, US)   Pharmaceuticals 52 42 54 91

February 29, 2024. Top 10s are published weekly following the . ( or for more stocks)


D.J. US Pharmaceutical Top 10: Combined Investment Strategy

TOP 10 Combined Investment Strategy Combined Strategy COMBINED Value Strategy VALUE Growth Strategy GROWTH 360° Strategy 360° VIEW
1. Pacira BioSciences (M, US)  Pharmaceuticals
1. Pacira BioSciences (M, US)   Pharmaceuticals 98 67 71 100
2. Phibro Animal (L, US)  Pharmaceuticals
2. Phibro Animal (L, US)   Pharmaceuticals 94 100 15 70
3. Nektar (S, US)  Pharmaceuticals
3. Nektar (S, US)   Pharmaceuticals 91 70 37 52
4. Assertio Therapeutics (S, US)  Pharmaceuticals
4. Assertio Therapeutics (S, US)   Pharmaceuticals 89 98 1 48
5. Amphastar (M, US)  Pharmaceuticals
5. Amphastar (M, US)   Pharmaceuticals 78 12 93 92
6. Pfizer (XXL, US)  Pharmaceuticals
6. Pfizer (XXL, US)   Pharmaceuticals 76 92 39 71
7. Johnson & Johnson (XXL, US)  Pharmaceuticals
7. Johnson & Johnson (XXL, US)   Pharmaceuticals 60 63 21 27
8. Heska (S, US)  Health Care Equipment
8. Heska (S, US)   Health Care Equipment 55 40 54 88
9. Supernus Pharma (M, US)  Pharmaceuticals
9. Supernus Pharma (M, US)   Pharmaceuticals 54 26 43 19
10. Prestige (L, US)  Pharmaceuticals
10. Prestige (L, US)   Pharmaceuticals 54 42 67 91

February 29, 2024. Top 10s are published weekly following the . ( or for more stocks)


☀ This company has a special achievement which is documented on its stock research page.

Top 10 lists may contain fewer than 10 stocks due to Obermatt’s top 10 quality standards.

Top 10 Stocks from the purely fact-based Obermatt Method in the stock index Dow Jones U.S. Pharmaceuticals Index from February 29, 2024.

Today's Top 10
More Top Stocks
Your Watchlist

Top 10 Stock History D.J. US Pharmaceutical



Obermatt Portfolio Performance
We’re so convinced about our research, that we buy our stock tips.
See the performance of the Obermatt portfolio.